IDEXX > Companion Animal > Education and Events > Diagnostic Edge Newsletter
 
diagnositc edge logo
July 2008 Issue 
In this issue:
•   Education: 9-year-old neutered male Australian shepherd Bailey was in acute collapse
•   Training and Events: See Webinars, seminars and online training opportunities available this month
•   IDEXX Innovations:
•   Health Watch: CAPC Road show brings you the latest information on emerging vector-borne disease.
•   Technical Tip:
•   Interactive Challenge: Earn FREE continuing education credit in the United States, Australia and parts of Canada! Identify a structure and its significance in urine sediment from a dog
 
Newsletter archive
Subscribe now
Print this page
Customer support is available 24/7 in the U.S. and Canada.
1-800-248-2483
 
IDEXX/EBI equine specialty reference laboratory site now at IDEXX Equine Health
AAHA Advocates Better Care for More Profit
Education
 

Featured case study:
9-year-old neutered male Australian shepherd, Bailey
Submitted by David Judy, DVM, Judy Veterinary Clinic, El Cajon, CA

Case Study: Bailey

Physical examination
Bailey was collapsed on presentation. He had pale mucous membranes, severe lethargy, rapid and weak femoral pulses, tachypnea and palpable abdominal fluid. There was a green discoloration/staining of all his paws. His temperature was 97.8° F, pulse 90 bpm and blood pressure 64/40 mmHg. He was determined to be in hypovolemic shock. Further inquiry regarding the green substance on Bailey’s paws raised the possibility of exposure to rodenticide. The owners thought that Bailey hadn’t been exposed, but a call to their son at home revealed that one of the rodent bait stations set behind a log pile had been pulled out and pellets were widely scattered. The pellets contained a second generation rodenticide containing 0.01% diphacinone.

Differential diagnoses
Signs of hypovolemic shock combined with palpable fluid in the abdomen is a potential sign of serious disease often carrying a poor prognosis. Abdominal fluid can be a result of any number of pathologic processes including transudates associated with hypoalbuminemia, exudates associated with active inflammatory disease, chylous effusions associated with lymphatic obstruction/destruction or even neoplastic effusions. Hemorrhage into the abdominal cavity is possible also and is most commonly secondary to trauma (unknown origin), a ruptured benign or neoplastic mass (splenic, hepatic, vascular) or a primary or secondary hemostatic disorder. A primary hemostatic disorder is less likely in this case as there was no mucosal surface bleeding, petechiae or ecchymoses. A secondary hemostatic disorder (coagulopathy) is much more likely if the abdominal fluid is hemorrhagic. A partial differential list for coagulopathy includes acquired or inherited clotting factor deficiency, hepatic disease/failure and rodenticide or other toxicity. Due to the probability of diphacinone ingestion, rodenticide toxicity was high on the differential list for this patient.

Diagnostic plan
A complete blood count (CBC), chemistry profile with electrolytes, and prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests were performed patient-side to screen for problems related to primary or secondary hemostasis and/or primary and secondary organ involvement or dysfunction. Abdominal radiographs and abdominocentesis were also performed to further evaluate the abdominal fluid palpated on the physical examination.

Laboratory data

Case study: hematology report

Erythron—All parameters were within reference interval limits except for the MCHC which was elevated. Elevation of MCHC (above the analyzer reportable range) may be due to the presence of cell-free hemoglobin due to in vitro or in vivo hemolysis or a combination of both.

Leukon—Although all parameters were within reference interval limits, the very low normal lymphocyte count is supportive of an underlying glucocorticoid influence (“stress”), which would be very understandable with Bailey’s clinical presentation. Evaluation revealed no significant morphology abnormalities including the presence of immature neutrophils or toxic neutrophil forms; therefore, no obvious inflammatory component is present.

Thrombon—A platelet count within the reference interval limit eliminated thrombocytopenia as a contributor to abdominal bleeding if it were present. Other primary hemostatic disorders due to thrombocytopathy, such as von Willebrand’s disease, would be uncommon given the history and signalment of the patient, but would be possible.

Clinical chemistry

Case study: chemistry report

Renal panel—The minimally increased BUN and creatinine indicate slight decreased glomerular filtration, which was likely secondary to hypovolemia, although a primary or secondary renal component was considered due to the critical status of the patient. A urinalysis to help characterize the azotemia (concentrated urine for hypovolemia and decreased perfusion—prerenal azotemia; nonconcentrated urine for primary or secondary renal component—renal azotemia) could not be obtained at this time due to the compromised status of the patient.

Electrolyte panel—Although the sodium and chloride are within reference interval limits, the chloride is slightly low relative to the sodium supporting a potential metabolic alkalosis associated with chloride loss or sequestration. Since no vomiting was reported in the clinical presentation, sequestration should be considered. The potassium was mildly decreased below the reference interval. If a significant alkalemia is present there could be a extracellular to intracellular shift of potassium associated with hydrogen ions moving out of the cells during alkalemia. All changes are extremely mild, but the pattern of mild changes are compatible with one another and further investigation, such as a complete acid-base characterization (Na, K, Cl, TCO2 and anion gap) and potential blood gas analysis, should be considered.

Glucose—The observed hyperglycemia was likely due to an endogenous glucocorticoid influence (“stress”) although possible diabetes mellitus would still have to be considered. An absence of glucose in the urine would be additional support for glucocorticoid affect; however, as is noted above, due to the compromised status of the animal, a urine sample could not be obtained.

Additional diagnostics

Case study: abdominal radiograph

Thoracic radiographs—the presence of mild microcardia and hypoperfused lungs supports hypovolemia.

Case study: thoracic radiograph

Abdominal radiographs—the loss of abdominal detail suggested abdominal effusion, such as hemorrhage. The urinary bladder appeared intact, indicating that uroperitoneum was unlikely.

Abdominocentesis—Frank blood was aspirated from the abdomen confirming the presence of abdominal hemorrhage.

Coagulation profile
A citrated PT and aPTT were prolonged beyond the analyzer reference interval limits indicating a problem with secondary hemostasis. (The reference interval limits for the citrated PT are 11–17 seconds and for the citrated aPTT are 72–102 seconds.) This profile can be seen with various conditions including consumptive coagulopathy (disseminated intravascular coagulopathy or DIC), selective factor deficiency in the common coagulation pathway as well as vitamin K antagonism (warfarin and diphacinone toxicosis).

Diagnostic summary
From the history, rodenticide toxicity was the primary differential for this patient, but there is always the question as to whether or not the animal actually ingested any rodenticide and whether the clinical signs are related specifically to rodenticide ingestion. Based on signalment, physical examination findings and laboratory data including identification of a lack of a thrombocytopenia, rodenticide toxicosis remained the primary differential. Bleeding into the abdominal cavity was more supportive of a secondary (coagulation) rather than primary (platelet or vascular related) hemostasis abnormality. Performing PT and aPTT tests
patient-side together with other laboratory data allowed for thorough evaluation of primary and secondary hemostasis. The lack of a severe or overwhelming inflammation as well as the lack of or no evidence of systemic illness or major organ dysfunction or injury strongly speaks against conditions like consumptive coagulopathy (DIC) as the cause of the coagulation profile abnormalities seen in this case. These findings are all supportive of rodenticide toxicosis.

Therapeutic plan
Bailey was treated with aggressive therapy for hypovolemic shock secondary to likely rodenticide toxicosis. Vitamin K1 was administered at 60 mg SC. His blood pressure was improved one hour after initiating shock therapy (97/80 mmHg) and his HCT and RBC were 31% and 4.79 M/µL respectively. He showed good clinical improvement to initial therapy and was referred to a local emergency clinic for continued overnight monitoring and treatment. Bailey was discharged from the emergency clinic in stable condition. The owners were instructed to keep him quiet and monitor him closely for any signs of bleeding, including hematoma formation and melena. They were further instructed to return to this hospital in three days for reevaluation and monitoring of the CBC and PT and aPTT (sooner if his status deteriorated). Vitamin K1 was dispensed at 2.5 mg/kg PO divided BID.

Clinical case outcome
Bailey was doing very well clinically at the time of his recheck. His CBC values were improved and a citrated PT and aPTT returned to within the reference interval limits (13 and 73 seconds respectively). Unfortunately, his owners did not return for reevaluation upon completion of the two-week course of vitamin K1 therapy as directed.

It was recommended that the PT be measured 48 hours after the last dose of vitamin K1 therapy. If Bailey were doing well clinically and the PT were normal, no further treatment would have been required. If the PT were prolonged, the recommendation would have been to continue vitamin K1 therapy for another two weeks then recheck the PT.

References:

  1. Cote E. Clinical Veterinary Advisor: Dogs and Cats. St Louis, Mo: Mosby; 2007:84–85.
  2. Duncan JR et al. Veterinary Laboratory Medicine: Clinical Pathology, 4th ed. Ames, Iowa: Iowa State University Press; 2003.
  3. Stockham SL et al. Fundamentals of Veterinary Clinical Pathology, 1st ed. Ames, Iowa: Iowa State University Press; 2008.

The recommendations contained in Diagnostic Edge educational materials are intended to provide general guidance only. As with any diagnosis or treatment, you should use clinical discretion with each patient based on a complete evaluation of the patient, including history, physical presentation and complete laboratory data. With respect to any drug therapy or monitoring program, you should refer to product inserts for a complete description of dosages, indications, interactions and cautions.

Tell us what you think of this case, or let us know if you have a case that you would like to submit. E-mail us at diagnosticedge@idexx.com to get the process started.


Training and Events
 

IDEXX Learning Center

The IDEXX Learning Center provides knowledge you can put into practice. Take part in the evolution of animal diagnostics through an ongoing educational partnership with leading veterinarians from across the globe and take advantage of a wide range of education resources, reference materials and events. Visit the IDEXX Learning Center to see a full listing of available Webinars, seminars and online training courses from IDEXX.
 

IDEXX Learning Center Create your own account on the IDEXX Learning Center and see how IDEXX can help you reach your educational goals!


Here are some of the opportunities available this month:

Webinars

See a full listing of Webinar opportunities >

Online training

See a full listing of online training opportunities >

Seminars

See a full listing of seminar opportunities >


Product innovations
 

IDEXX Dry-Slide Technology: The Most Accurate Testing Option

Dry-slide technology is the most highly developed technology available for in-house chemistry testing. Unique layers remove impurities for the most accurate results, even on samples that are compromised by icterus, hemolysis or lipemia—often unavoidable events in veterinary medicine.

Dry-slide technology

Thousands of veterinary practices worldwide have relied on this technology for trusted results from their VetTest® Chemistry Analyzers for years. Today, IDEXX also offers this technology with the Catalyst Dx™ Chemistry Analyzer.

*Study on file with IDEXX Laboratories
† Article published in full, Advanced Diagnostics, NAVC Clinician’s Brief, November 2007.

For more information on IDEXX dry-slide technology or the VetTest or Catalyst Dx analyzers, please visit www.idexx.com/vetlab or call us at
1-800-355-2896.


New Cornerstone® Coaching Series from IDEXX Computer Systems
Helping practices incorporate information systems into practice workflow

Cornerstone coaching series

One of the most overlooked aspects of many practices is the software that manages critical information about patients, clients and nearly every part of daily operations—from scheduling appointments to adding diagnostic results to patient medical records and creating invoices.

IDEXX Computer Systems is helping to address this issue with a recently created series of educational services targeted to help you better understand, manage and incorporate your information systems into your practice workflow. The Cornerstone Coaching series provides custom assessment and learning solutions based on industry best practices to help create more effective utilization of information management technology.

“Customers have asked how we can help them take their practice performance to the next level,” says Brenda Martineau, learning and performance manager for IDEXX Computer Systems. “A key part of attaining their goals is looking for better tools to review, benchmark and improve upon their practice...”

The series includes analysis and reporting performed by IDEXX learning and performance experts and instructor-led Web-based training on a host of subjects including:

  • Use of electronic medical record capabilities
  • Inventory management
  • Database utilization
  • Much more

The Cornerstone Coaching series addresses more than the technological aspects of the Cornerstone® software. It will help you determine how your current software is being used, identify the processes needed to support your goals, and decide how Cornerstone can best be used to manage and report on progress.

For more information about the Cornerstone Coaching series, contact your IDEXX Computer Systems representative at 1-800-283-8386, option 2.


Health Watch
 

CAPC Road Show

The CAPC parasitologists are traveling the country this summer to bring you the latest information on emerging vector-borne disease, zoonotic potential and parasite control for dogs and cats. Look for a CAPC Road Show program in your area and receive continuing education (CE) credit for attending.


Technical Tip
 

Important IDEXX slide and SNAP® test ordering information

With the recent addition of the Catalyst Dx™ and the SNAPshot Dx™ analyzers to the IDEXX VetLab® Suite, there are now more test ordering options. To ensure you receive the correct slides and SNAP tests, please clearly specify which analyzer you use. If you don’t specify which analyzer you use, the wrong tests may be ordered, and they will not run on your analyzer.

Slide and SNAP test ordering tip

NOTE: Catalyst Dx Analyzer slides and CLIPs are trapezoidal; VetTest Analyzer slides are rectangular. The SNAP tests all look the same.

IDEXX VetTest® Analyzer and Catalyst Dx Analyzer users:
When ordering prepackaged panels, single slides or preloaded CLIPs, please specify whether they are for use with the IDEXX VetTest Analyzer or Catalyst Dx Analyzer.

IDEXX SNAP® Reader Analyzer and SNAPshot Dx Analyzer users:
When ordering SNAP T4 tests, please specify whether they are for use with the SNAP Reader Analyzer or the SNAPshot Dx Analyzer.

SNAP cortisol and bile acids tests are the same and will work in either analyzer.

If you have any questions about this information, please call IDEXX at
1-800-355-2896.


Increased SNAP® Integration in the IDEXX VetLab® Station Patient Report

We’ve added several new interpretive guides to IDEXX VetLab® Station software (version 2.31), including guides for each of the SNAP test results. These explanations offer valuable background information, which can be particularly helpful as an aid in discussing diagnostic results with your clients.

This newest software version also allows you to automatically generate a report that includes all of the SNAP test results entered into the IDEXX VetLab Station. The report can be created for a specific time frame and eliminates the need to maintain a separate manual log for SNAP test results. SNAP test results are also automatically printed in the IDEXX VetLab Station patient report along with the rest of your patient’s diagnostic results, so you’ll always have a complete look at a patient’s health status.

These features apply to the new SNAP® Feline Triple™ Test—coming soon—which tests cats for feline immunodeficiency virus (FIV) antibody, feline leukemia virus (FeLV) antigen and now, feline heartworm antigen. The test is highly specific for diagnosing feline heartworm disease. This three-in-one test for feline infectious disease introduces an enhanced tool to promote feline health care at no additional cost.

The SNAP Feline Triple Test is recommended for sick cats, at-risk cats and cats that will be placed on heartworm prevention.

Visit our Web site for more information on the IDEXX VetLab Station (www.idexx.com/vetlabstation) or IDEXX SNAP tests (www.idexx.com/snap) or call us at 1-800-355-2896.

SNAP integration in IDEXX VetLab

interactive challenge

With FREE continuing education credit!*

NOW approved in the United States, Australia and parts of Canada!

Have you taken advantage of every qualifying Interactive Challenge for FREE continuing education (CE) credits?

Each Interactive Challenge from June 2006 and on has been worth 0.5 continuing education credit in the United States—and you get the credit just for participating! Check out the Diagnostic Edge archive and take any qualifying challenges you may have missed. Don’t let these fun credits slip away!

interactive challenge
Figure 1: Urine sediment from a dog, unstained, high power (40x objective) field of view.

All fields are required for CE credit records.

Questions:

  1. Which of the following is the BEST identification of the large, elongate, curved structure in the center of the field of view?
a. Mucus
b. Waxy cast
c. Protein cast
d. Cellular cast
e. Granular cast
f. Mixed waxy-cellular cast
g. Mixed waxy-granular cast
h. Mixed protein-granular cast
  1. What is the greatest significance of this finding?
a. No significance, normal finding
b. Presence of significant proteinuria
c. Increased mucus production within renal tubules
d. Inflammation within renal parenchyma
e. Renal tubular injury
 
Name
Practice Name
AVA number (Australia Only)
Address
City
State/Province
Country/Territory
Postal/ZIP Code
Telephone
E-mail Address
Confirm Your E-mail Address

We respect your privacy. For more information, review our privacy policy.

Please include the e-mail address diagnosticedge@idexx.com in your approved senders list to ensure that your e-mail provider will allow you to receive this confirmation. View instructions on how to do this with the most common e-mail service providers.

Not a Diagnostic Edge subscriber? Subscribe now!

All fields are required for continuing education credit records.

Thanks for taking the Diagnostic Edge Interactive Challenge!

*Each interactive challenge meets the requirements for 0.5 hour of continuing education credit in jurisdictions that recognize AAVSB’s RACE approval, however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

AAVSB Provider Number 106

Interactive challenges are also approved in Australia for 0.5 AVA Vet Ed Point and from the following Canadian Veterinary Medical Associations: Alberta, Saskatchewan, New Brunswick and Prince Edward Island.

All ®/TM marks are owned by IDEXX Laboratories, Inc. or its affiliates in the United States and/or other countries.


This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.